Caesarean section and phaeochromocytoma resection in a patient with Von Hippel Lindau disease.
This report describes the anaesthetic management of a women with a term gestation, Von Hippel Lindau disease (VHLD), and a phaeochromocytoma, scheduled for a combined phaeochromocytoma resection and Caesarean section. Von Hippel Lindau disease is characterized by diffuse haemangioblastomas of the central nervous system (CNS) and viscera. It is also associated with phaeochromocytomas and renal cell carcinomas. Patients frequently have asymptomatic spinal cord and intracranial pathology. The patient and her fetus presented a challenge because of the anaesthetic restrictions imposed by VHLD, and her pregnancy. She was also at risk of developing malignant hypertension from the phaeochromocytoma. The patient was not a candidate for regional anaesthesia because of the possibility of spinal cord haemangioblastomas. She had received adrenergic blockade with phentolamine (total 30 mg a day) and propranolol (total 40 mg a day) since the 27th wk of gestation in order to control hypertension secondary to the phaeochromocytoma. General anaesthesia was administered with aggressive management of hypertension with adrenergic blockers (labetalol 1.0 mg.kg-1 and esmolol 0.75 mg.kg-1) and sodium nitroprusside 1.5 micrograms.kg-1 (total). Before delivery of the baby, opioids, which could have resulted in a fetus with CNS depression, were avoided. After delivery, opioids (sufentanil 0.4 microgram.kg-1 x hr-1) were used to limit the use of inhalational anaesthesia which may contribute to uterine atony. Postoperative pain was managed with an intravenous narcotic infusion. Both patients had uneventful postoperative courses.
Joffe
D
D
Department of Anaesthesia and Obstetrics, McGill University, Montreal, Quebec.
Robbins
R
R
Benjamin
A
A
D000310:Adrenal Gland Neoplasms / Q000601:surgery*; D000328:Adult; D000768:Anesthesia, General; D000769:Anesthesia, Inhalation; D000771:Anesthesia, Intravenous; D000773:Anesthesia, Obstetrical; D002585:Cesarean Section; D005260:Female; D006801:Humans; D008012:Lidocaine; D008874:Midazolam; D010673:Pheochromocytoma / Q000601:surgery*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular; D011252:Pregnancy Complications, Neoplastic / Q000601:surgery*; D013390:Succinylcholine; D017409:Sufentanil; D013874:Thiopental; D006623:von Hippel-Lindau Disease / Q000150:complications*
D008012:Lidocaine; D017409:Sufentanil; D013390:Succinylcholine; D013874:Thiopental; D008874:Midazolam